ReviewActa neurochirurgica2026
Efficacy and safety of full-endoscopic sacroiliac joint denervation for the treatment of chronic low back pain: a systematic review.
Review in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFull-endoscopic sacroiliac joint denervation (FE-SJD) is a novel minimally invasive technique that increases the precision of targeting the nerve roots responsible for chronic low back pain (CLBP). The purpose of this study is to evaluate the safety and efficacy of FE-SJD for the management of CLBP attributable to sacroiliac joint (SIJ) dysfunction.
methodsA systematic search of PubMed/MEDLINE, Cochrane Library, and Google Scholar using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was conducted to collect studies assessing the effectiveness and safety of FE-SJD in the treatment of CLBP of SIJ origin.
resultsA total of 6 studies encompassing 169 patients were included. The weighted age of patients was 59.95 ± 12.07 years with 102 (60.36%) females. The weighted mean of BMI was 26.82 ± 4.62. All patients presented with SIJ-attributable CLBP, with an average duration of 55.0 ± 28.0 months. The most common treated level was L4-5 with a mean operation time of 44.0 ± 11.2 min. The preoperative Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) weighted mean were 6.675 ± 1.294 and 34.4 ± 6.99 which significantly improved to 2.46 ± 1.65 and 12.3 ± 5.47 at the latest follow-up, respectively (P < .001). The mean follow-up period was 18 ± 9.75 months. There were no complications.
conclusionThe available evidence suggests that FE-SJD is associated with favorable clinical outcomes and a low complication rate in the treatment of chronic low back pain attributable to sacroiliac joint dysfunction. However, the current literature is limited by small sample sizes and predominantly non-comparative study designs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.